[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid, 98%, 98%

cas: 847499-27-8 — see every product listed under this CAS number, including other names

[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid, 98%, 98% (CAS 847499-27-8) is a chemical reagent available from Chemat. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 1mg, 2mg, 100mg, 250mg. Offered by: Chemat.

• 2D
• 3D

Delanzomib is a C-terminal boronic acid peptide inhibitor which induces apoptosis in multiple myeloma, hematological and solid tumor cell lines. It has a role as an antineoplastic agent, a proteasome inhibitor and an apoptosis inducer. It is a C-terminal boronic acid peptide, a threonine derivative, a secondary alcohol and a phenylpyridine. It is functionally related to a L-threonine.

Source: ChEBI

Identity

Molecular formula	C21H28BN3O5
Molecular weight	413.3 g/mol
IUPAC name	[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid
InChIKey	SJFBTAPEPRWNKH-CCKFTAQKSA-N
SMILES	B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O

Computed by PubChem (NCBI)

Synonyms: Delanzomib, delanzomibum, Proteasome Inhibitor CEP 18770, Delanzomib (CEP-18770), Delanzomib [USAN:INN], Delanzomib [USAN], Delanzomib (USAN), Delanzomib, free base, DELANZOMIB [INN], DELANZOMIB [WHO-DD]